BDO Wealth Advisors’s Redhill Biopharma RDHL Stock Holding History

BDO Wealth Advisors’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$30	Hold	1	–	–	﹤0.01%	975
2023 Q1	$103	Hold	1	–	–	﹤0.01%	1043
2022 Q4	$140	Hold	1	–	–	﹤0.01%	993
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	993
2022 Q2	$1K	Hold	1	–	–	﹤0.01%	1003
2022 Q1	$3K	Hold	1	–	–	﹤0.01%	900
2021 Q4	$3K	Hold	1	–	–	﹤0.01%	910
2021 Q3	$5K	Hold	1	–	–	﹤0.01%	830
2021 Q2	$7K	Hold	1	–	–	﹤0.01%	819
2021 Q1	$7K	Hold	1	–	–	﹤0.01%	800
2020 Q4	$8K	Hold	1	–	–	﹤0.01%	580
2020 Q3	$10K	Buy	+1	New	+$8.2K	﹤0.01%	495

Other funds holding RDHL

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MOS

MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BDO Wealth Advisors's RDHL Position: Q2 2023 in Review

BDO Wealth Advisors held its Redhill Biopharma (RDHL) position steady in Q2 2023 at 1 share worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #975.

BDO Wealth Advisors first reported a position in RDHL in Q3 2020 and has held it in 12 quarters since. The position peaked at $10K in Q3 2020. 18 funds tracked by Wall St. Rank hold RDHL as of Q2 2023.

BDO Wealth Advisors held 1 share of Redhill Biopharma worth $30 as of Q2 2023.
BDO Wealth Advisors left its Redhill Biopharma share count unchanged in Q2 2023.
Redhill Biopharma made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #975 holding.
BDO Wealth Advisors first reported a position in Redhill Biopharma in Q3 2020 and has held it in 12 quarters since.
BDO Wealth Advisors's Redhill Biopharma position peaked at $10K in Q3 2020.
18 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.